Sensitivity to fadraciclib was increased in AML and ALL cell lines carrying MLLr/MLL-PTD (Fig 4A and 4B, S2 Fig and S7 Table), and this may be due to dependence on the MLL-mediated transcription of HOXA9/MEIS1. This evidence concerns the gene HOXA9 and acute lymphoblastic leukemia.